Rare Pediatric Disease Designation Awarded to Investigative Therapy for POMC and LEPR Deficiency Obesities
source: pixabay.com

Rare Pediatric Disease Designation Awarded to Investigative Therapy for POMC and LEPR Deficiency Obesities

Rare pediatric disease designation has just been granted to Rhythm Pharmaceuticals for their investigative therapy called setmelanotide. This drug is being investigated as a therapeutic option for two conditions- leptin…

Continue Reading Rare Pediatric Disease Designation Awarded to Investigative Therapy for POMC and LEPR Deficiency Obesities
Familial Chylomicronemia Syndrome Foundation Announces Support for HEART Act
https://pixabay.com/en/book-book-gift-heart-gift-read-1760998/

Familial Chylomicronemia Syndrome Foundation Announces Support for HEART Act

  In a July 9 press release, the Familial Chylomicronemia Syndrome (FCS) Foundation announced its support for a bill introduced by Congressman Paul Tonko (D-NY) and David B. McKinley (R-WV).…

Continue Reading Familial Chylomicronemia Syndrome Foundation Announces Support for HEART Act